Trump aides have begun inserting their own people into the Department of Health and Human Services and, in some cases, taking direct control of operations at the agency, as internal concerns mount that Secretary Robert F. Kennedy Jr.'s tenure could become a liability for Republicans heading into the 2026 midterm elections.

The White House has personally intervened to replace some of Kennedy's top officials with people of their own choosing, according to reporting from The Wall Street Journal and The Daily Beast.

The moves reflect a growing unease inside the administration that Kennedy's focus on vaccine skepticism and a string of operational missteps are creating political exposure the party cannot afford.

White House spokesperson Kush Desai disputed any suggestion of a rift:

"The Trump administration has delivered one MAHA win after another, and the White House continues to work hand in glove with Secretary Kennedy and the entire HHS team to keep more MAHA wins coming for the American people."

That is the official line. The actions tell a different story.

The political math behind the intervention

One administration official told the Washington Post last month that vaccine messaging is a political minefield. The official's reasoning was blunt: "Vaccines are not popular issues to talk about." When pressed, the official added: "It goes back to polling."

That kind of candor is rare in any White House. It also reveals the central tension at play. The Make America Healthy Again vision that Kennedy champions has a real constituency.

Millions of Americans are genuinely concerned about what goes into their food, their children's bodies, and the regulatory capture of agencies meant to protect public health. Those concerns are legitimate, and the political energy behind them is real.

But translating that energy into competent governance is a different challenge entirely. And by the administration's own apparent assessment, Kennedy's HHS has struggled on that front. The reported missteps include:

• Failing to control a widespread measles outbreak
• Canceling grants for mental health and substance abuse programs
• Ongoing drama at the FDA

None of those are small things. A measles outbreak is the kind of crisis that demands swift, visible competence from a health agency. Grant cancellations touch real communities. And instability at the FDA rattles an industry and a public that depend on it, whatever you think of the agency's track record.

According to the Journal's reporting, Kennedy's standing among some staff is at "a new low." Kennedy himself was reportedly receptive to the White House's changes and told subordinates the department was losing "friends."

Trump's balancing act

The president himself has shown no public daylight with Kennedy. In February, Trump praised his HHS secretary warmly:

"He's doing such a fantastic job."

"Who would've thought a Kennedy—we love a Kennedy—in the Republican Party?"

The Journal also reported that Kennedy remains in good standing with the president. That matters. Cabinet secretaries survive or fall based on one relationship, and Kennedy still has it.

But the operational reality has clearly shifted. Trump originally told Kennedy to "go wild on health." The White House is now quietly defining what "wild" means and, more importantly, what it doesn't.

During his State of the Union address last month, Trump did not discuss any MAHA priorities. He briefly mentioned his efforts to lower prescription drug prices. That omission speaks volumes about where the White House sees the political upside right now, and where it doesn't.

The glyphosate contradiction

One episode captures the internal complexity neatly. Kennedy has long opposed glyphosate-based pesticides and, as an environmental lawyer, successfully sued one manufacturer over allegations that the pesticide causes cancer. One of the most well-known brand names is Roundup.

Trump signed an executive order in February to boost the domestic production of glyphosate.

That is not a minor policy disagreement. It is a direct collision between the president's agricultural and economic priorities and his health secretary's longstanding convictions. The fact that it has not erupted into a public fight suggests both men understand the stakes. But it also illustrates why the White House feels the need to keep a tighter hand on the wheel at HHS.

What this actually means for 2026

The midterm anxiety is not abstract. Republicans are watching the political landscape and calculating which issues help and which ones hurt. Vaccine skepticism, whatever its merits as a policy conversation, polls poorly with the general electorate. That is simply a fact of the current political environment, and the administration knows it.

The smart play here is obvious: keep the MAHA branding, keep the energy, keep the base engaged on food safety and chronic disease and institutional accountability at federal health agencies.

Those are winning issues. But separate the popular mission from the unpopular messenger problems. Staff the department with people who can execute without generating weekly headlines about operational failures.

That appears to be exactly what the White House is doing. It is not abandoning Kennedy. It is building guardrails around him. The distinction matters.

Kennedy's instincts on institutional reform at HHS are shared by millions of voters who watched federal health agencies spend the pandemic years shredding their own credibility.

The appetite for change at these agencies is genuine and deep. But the vehicle for that change has to be roadworthy. Right now, the White House is under the hood making repairs while the car is still moving.

Whether Kennedy accepts the new arrangement gracefully or chafes against it will determine how this chapter ends. For now, the president has his arm around Kennedy's shoulder in public and his hand on the steering wheel in private. That is governance. The question is whether it holds through November.